ECPELLA as a  bridge-to-decision in refractory cardiogenic shock: a single-centre experience

CONCLUSION: ECPELLA can be successfully used as a bridge to LVAD implantation or as a bridge-to-recovery in patients with refractory cardiogenic shock. Despite a significant number of complications, 30-day mortality was lower than observed in previous cohorts.PMID:38713449 | DOI:10.1007/s12471-024-01872-w

Source: Netherlands Heart Journal - May 7, 2024 Category: Cardiology Authors: Jan-Willem Balder Mariusz K Szymanski Linda W van Laake Pim van der Harst Christiaan L Meuwese Faiz Z Ramjankhan Manon G van der Meer Jeannine A J M Hermens Michiel Voskuil Eric E C de Waal Dirk W Donker Marish I F J Oerlemans Adriaan O Kraaijeveld Source Type: research